Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Travecta Therapeutics Pte. Ltd.
BioCentury | Nov 1, 2024
Management Tracks
Masashi Miyamoto to become chairman and CEO of Kyowa Kirin
Plus: Scott Koenig to step down as CEO of MacroGenics, and updates from Axonis and Myrobalan
BioCentury | Oct 28, 2021
Management Tracks
Labinger out as Checkmate CEO
Plus: Travecta, MTS Health Partners, Elevar and Y Combinator
BioCentury | Jun 9, 2021
Management Tracks
More C-suite changes for Karyopharm; plus moves at Intercept, Chinook, Palleon, Napo, IMV and more
In another change in the C-suite of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Chief Commercial Officer John Demaree and SVP of Sales Perry Monaco are leaving to pursue other opportunities. The
BioCentury | May 14, 2020
Finance
May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic
Items per page:
1 - 5 of 5